Maze Therapeutics, Inc.(MAZE)
NASDAQ
$31.01
-0.94 (-2.94%)

Maze Therapeutics, Inc.(MAZE)Earnings Date, History & Expected Move
NASDAQ

MAZE is scheduled to report on Nov 5, 2026. Analysts expect EPS of -$0.79.

Next report
Nov 5, 2026
In 12 days
EPS beat rate
50%
3 of 6 quarters
Avg move after earnings
±10.1%
Up 25% of the time · last 4
Options-implied move
—
No reliable options quote yet

EPS: Actual vs Estimate

Reported EPS against the consensus estimate, last 6 quarters.

Green beat or met, red missed, amber sources differ.

Stock Reaction After Earnings

Close-to-close move in the first session that reflected each report.

Dashed lines mark the average actual move (±10.1%).

Did the stock rise after good news?

The next-day move after each of its last 3 EPS beats and 1 misses.

When it beat expectations
3 reports
When it missed expectations
1 report

In plain words: it beat expectations 3 times, but the stock still fell 3 of those 3 times.

Report by report
  • Aug '26
    Missed
    ▲ +0.8%
  • Mar '26
    Beat
    ▼ -35.2%
  • Nov '25
    Beat
    ▼ -3.5%
  • Aug '25
    Beat
    ▼ -1.0%

Clear beats and misses with a known reaction only. What counts as a beat

After an EPS beat
-13.3%
average next-day move · up 0% of 3 times
After an EPS miss
—
Not enough quarters yet

Why did MAZE fall after beating earnings?

4 of MAZE's last 4 reactions went against the EPS result. What stands out in each:

MAZE beat EPS estimates in 3 quarters, and the stock still closed lower the next day 3 times. In 1 of the 3 where we have price data, the stock had already run up before the report.

  • Mar 25, 2026EPS beat +5.8%stock -35.2% next day
    • It had risen 8.2% in the 20 trading sessions before the report, so good news may already have been priced in.
    • It opened 18.4% lower as soon as trading resumed.
  • Nov 6, 2025EPS beat +4.3%stock -3.5% next day

    Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.

  • Aug 12, 2025EPS beat +33.0%stock -1.0% next day
    • It opened 1.9% higher, but sellers took over and it closed -1.0%.

Rose despite an EPS miss (1 of 1)

  • Aug 11, 2026EPS missed -8.6%stock +0.8% next day
    • It had already fallen 8.6% in the 20 trading sessions before the report, so weak results may have been expected.

Patterns in estimates and prices, not confirmed causes: how we read them.

Was MAZE's earnings move already priced in?

MAZE's move in the month before each of its last 4 reports, against what it did after.

Avg move in the month before
-2.9%
last 4 reports
Higher before the report
50%
of the time

How the run-up is measured (a move of 5% or more counts as large).

Before vs after each report

Grey: the month before each of the last 4 reports. Green or red: the day after.

Past reports only. How the run-up is measured

MAZE earnings history

Last 6 reported quarters with the stock's reaction.

Swipe sideways to see every column →

Report dateTimeEPS est.EPS actualSurprise1-day move3-day move
Aug 11, 2026After close-$0.70-$0.76-8.6%+0.81%-0.48%
Mar 25, 2026Before open-$0.69-$0.65+5.8%-35.24%-38.00%
Nov 6, 2025After close-$0.69-$0.66+4.3%-3.48%+8.88%
Aug 12, 2025After close-$1.15-$0.77+33.0%-1.02%-1.75%
May 14, 2025After close-$0.63-$1.15-82.5%——
Mar 31, 2025Before open$0.45-$18.32-4171.1%——

Consensus for the next report: EPS -$0.79, revenue $0.00.

MAZE Earnings FAQ

Answers computed from Maze Therapeutics, Inc.'s reported history

MAZE is scheduled to report on Nov 5, 2026. Analysts expect EPS of -$0.79.

Over the last 6 quarters with a usable EPS surprise, MAZE beat the consensus estimate 3 times (50%), missed 3 and landed in line 0.

Across its last 4 quarters with a measured reaction, MAZE moved an average of ±10.1% in the first session after reporting. It closed higher 25% of the time; the largest gain was 0.8% and the largest drop -35.2%.

Across its last 4 quarters with price data, MAZE moved an average of -2.9% in the 20 trading sessions before reporting and was higher in 50% of them. This describes past reports; it is not a forecast.

How we calculate these numbers · MAZE: 6 reported quarters, latest Aug 11, 2026. Information only, not investment advice.